Several original studies have investigated the association between ADPRT Val762Ala and APE1 Asp148Glu polymorphisms and risk of breast cancer, but the results remain inconsistent, partially due to insufficient power in each of published studies which have been based on relatively small sample sizes. The gene discussed is PARP1; the disease is breast cancer.